Kopran Limited (BOM:524280)
India · Delayed Price · Currency is INR 142.55
-2.50 (-1.72%)
At close: Jan 19, 2026
Kopran Revenue
Kopran had revenue of 1.94B INR in the quarter ending December 31, 2025, with 16.91% growth. This brings the company's revenue in the last twelve months to 6.19B, down -3.86% year-over-year. In the fiscal year ending March 31, 2025, Kopran had annual revenue of 6.30B with 2.44% growth.
Revenue (ttm)
6.19B
Revenue Growth
-3.86%
P/S Ratio
1.02
Revenue / Employee
6.04M
Employees
1,024
Market Cap
6.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 6.30B | 150.13M | 2.44% |
| Mar 31, 2024 | 6.15B | 636.05M | 11.54% |
| Mar 31, 2023 | 5.51B | 734.66M | 15.38% |
| Mar 31, 2022 | 4.78B | -142.93M | -2.91% |
| Mar 31, 2021 | 4.92B | 1.32B | 36.81% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anuh Pharma | 7.30B |
| Venus Remedies | 6.99B |
| Lincoln Pharmaceuticals | 6.32B |
| Wanbury | 6.31B |
| Sudarshan Pharma Industries | 5.92B |
| Fredun Pharmaceuticals | 5.31B |
| Bharat Parenterals | 3.57B |
| Accent Microcell | 2.78B |